BIOMARKER:

EGFR C797S + EGFR T790M + EGFR exon 19 deletion

C3 | Sensitive

D | Sensitive

C3 | Resistant

D | Resistant

Show legend

Include preclinical:

Drug categories

EGFR

Tyrosine Kinase Inhibitors

Non Small Cell Lung Cancer

BBT-176

EGFR C797S + EGFR T790M + EGFR exon 19 deletion|Non Small Cell Lung Cancer|BBT-176

CH7233163

EGFR C797S + EGFR T790M + EGFR exon 19 deletion|Non Small Cell Lung Cancer|CH7233163

osimertinib + BLU-945

EGFR C797S + EGFR T790M + EGFR exon 19 deletion|Non Small Cell Lung Cancer|osimertinib + BLU-945

panitumumab + iruplinalkib

EGFR C797S + EGFR T790M + EGFR exon 19 deletion|Non Small Cell Lung Cancer|panitumumab + iruplinalkib

TAS3351

EGFR C797S + EGFR T790M + EGFR exon 19 deletion|Non Small Cell Lung Cancer|TAS3351

H002

EGFR C797S + EGFR T790M + EGFR exon 19 deletion|Non Small Cell Lung Cancer|H002

HJM-561

EGFR C797S + EGFR T790M + EGFR exon 19 deletion|Non Small Cell Lung Cancer|HJM-561

iruplinalkib + QL1203

EGFR C797S + EGFR T790M + EGFR exon 19 deletion|Non Small Cell Lung Cancer|iruplinalkib + QL1203

JIN-A02

EGFR C797S + EGFR T790M + EGFR exon 19 deletion|Non Small Cell Lung Cancer|JIN-A02